Fig. 3From: Improved uptake and survival with systemic treatments for metastatic non-small cell lung cancer: younger versus older adultsMedian overall survival for <70 years and ≥70 years by line of treatmenta) first line treatment (platinum doublet vs. targeted therapy)b) second line treatment (single agent chemotherapy vs. immunotherapy)Back to article page